Search

everythinglearnresearchcommunity

for

Search:↓

A reliable method was created to measure dutasteride and related molecules in capsules.

Two non-steroidal antiandrogens, RU 58841 and RU 56187, form a common metabolite at different rates, which may influence their effects; RU 56187 could be used for prostate cancer treatment and RU 58841 for acne treatment.

A 17-year-old female with adrenogenital syndrome produces very high levels of androgens, which prevent complete feminization despite high estrogen doses.

Researchers created a new, efficient way to make Dutasteride, a hair loss and prostate drug, with high purity using a benzoyl group.

The method accurately measures certain steroids in human hair, showing different levels in males and females.

GI197111X is best dissolved in Capmul MCM for trials.

New steroid derivatives show promise as anticancer agents, even against resistant cells.

In 2017, a new method was created to efficiently produce a topical antiandrogen, a compound used to treat excess sebum and acne, with a high yield and purity.

Researchers developed new compounds that target the androgen receptor effectively with fewer side effects.

New pregnane derivatives are effective at inhibiting an enzyme linked to hair loss and reducing oil gland activity.

The new method for making Finasteride is cheaper and safer for large-scale production.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by affecting androgen functions and suppressing certain hormones.

A new compound may effectively inhibit the enzyme linked to BPH and hair loss.

Cyproterone acetate is used to treat conditions like prostate cancer, early puberty, excessive sexual drive, and female androgenization by blocking male sex hormones.

New compounds show promise for treating benign prostate hyperplasia with fewer side effects.

The new method for making finasteride is cheaper and gives a higher yield.

Four new compounds were more effective than finasteride in treating prostate issues and hair loss, with one being 100 times more active and safe for use.

5α-reductase inhibitors can interfere with doping tests by masking banned substances.

Androstanediol glucuronide is a reliable marker for hirsutism in women.

New genes and pathways are important for testosterone production and male sexual development.

A new treatment for hair loss shows promise with fewer side effects.

Clascoterone cream could be used for other skin conditions affected by hormones.

TrichoFoam™ effectively delivers multiple hair loss treatments, maintaining their stability and effectiveness.